Researchers supported by the National Institutes of Health are launching a clinical trial to test a device that uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus, a persistent buzzing or ringing sound in the ears in the absence of any real sound.
The small clinical trial, which is recruiting volunteers, is being conducted at four centers through a cooperative agreement with MicroTransponder, Inc., a medical device company based in Dallas.
Source: NIH Press Release
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1dJ5Cqa
Cap comentari:
Publica un comentari a l'entrada